Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06308393

Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects

A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Pharmacokinetic Profile of RSS0393 Ointment as a Single and Multiple Dose Ascending Local Dermal Administration in Healthy and Adult Subjects With Psoriasis

Status
Active Not Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
98 (actual)
Sponsor
Jiangsu HengRui Medicine Co., Ltd. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Randomized, double-blind, placebo-controlled study of RSS0393 ointment in healthy and psoriatic subjects

Conditions

Interventions

TypeNameDescription
DRUGRSS0393 ointment;PlaceboRSS0393 ointment;RSS0393 ointment placebo

Timeline

Start date
2024-03-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2024-03-13
Last updated
2025-05-02

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06308393. Inclusion in this directory is not an endorsement.